Rare diseases
Investigational molecules
Locations
Back to Italy920 clinical trials in Treviso, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
ItalyStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
ItalyStudy on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
ItalyComparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission
ItalyStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
ItalyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
ItalyStudy on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation
ItalyStudy on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia
ItalyStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
ItalyStudy on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases
ItalyStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
ItalyStudy of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Acute Myeloid Leukemia and Lymphomas, including studies on targeted therapies combined with standard chemotherapy. Research focuses on improving treatment outcomes for various blood cancers.
Advanced therapeutic approaches aim to enhance minimal residual disease control and patient outcomes.
Comprehensive research into ovarian cancer treatments, including studies of maintenance therapies and novel drug combinations. Investigations focus on both recurrent and newly diagnosed cases.
Studies emphasize personalized treatment approaches based on specific genetic markers and disease characteristics.
Groundbreaking research in lung cancer and severe respiratory conditions, including targeted therapies for specific genetic mutations and innovative treatment combinations.
Focus on developing personalized treatment strategies for various lung cancer subtypes and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
